UAEM - Licensing and patenting practices of COVID-19 technologies

Sarai Keestra made this Freedom of Information request to Keele University

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was successful.

Dear Keele University,

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:
Q1. Can you release your internal strategy regarding licensing and patenting of COVID-19 related health technologies?

Q2. Does the institution have a formal policy on licensing and patenting of COVID-19 related technologies? If yes, please provide a link or PDF to the relevant policy document.

Q3. Has the university considered updating their strategy regarding the licensing and patenting of health technologies since the start of the pandemic?

Q4. Please provide an Excel spreadsheet with headings as displayed below with all the COVID-19 related health technologies LICENSED by the university AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q5. Please provide a list of patents granted to your organization for any COVID-19 related health technologies listed by patent family, indicating countries/regions in which the patent has been granted.

Q6. Does the institution have any plans on signing up to the Open-COVID pledge (https://opencovidpledge.org/) or any similar initiative that seeks to minimise intellectual property rights barriers during the COVID-19 pandemic? If yes, please specify.

Q7. Is the institution considering the licensing of COVID-19 related health technologies to the Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool (MPP) during the pandemic? If yes, please specify.

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

foi, Keele University

Dear Sarai, 

Ref: 2020/224/LN

 
Thank you for your email requesting information from Keele University. 
 
Your request will be processed and a response provided to you as soon as
possible within 20 working days. 

Best wishes

__________________________________________ 

Freedom of Information 

Legal, Governance & Compliance
Student and Academic Services
Tawney Building | Keele University | Staffordshire | ST5 5BG 

Email: [1][Keele University request email] | Website: [2]www.keele.ac.uk/foi/
Tel: Lauren A 34311 | Laura N: 34633 | Jo S: 33589 

[3]Please consider the environment before printing

This email and its attachments may be confidential; if it has come to you
in error you should not copy or show it to anyone; nor should you take any
action based on it, other than to notify the sender immediately. 

--------------------------------------------------------------------------

From: Sarai Keestra <[FOI #702214 email]>
Sent: 27 October 2020 12:22
To: foi <[Keele University request email]>
Subject: Freedom of Information request - UAEM - Licensing and patenting
practices of COVID-19 technologies
 
Dear Keele University,

For the purpose of clarity, please adhere to the following definitions
when answering these questions:

Low and middle income country: A country that is defined as ‘low’,
‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year
2018. Income status defined by GNI per capita.

Source: World bank, available online [[4]https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention.
A patent holder can stop other people from selling, manufacturing,
producing, or using the invention for a certain period of time.

Source: Upcouncil, available online
[https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property
rights

Source: TaylorWessing, available online
[https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to
exploit the relevant IP rights, the licensor is also excluded from
exploiting these IP rights.

Non-Exclusive Licence: A licence that grants any number of licensees to
exploit the IP.

Source: TaylorWessing, available online
[https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health
technology is the application of organized knowledge and skills in the
form of devices, medicines, vaccines, procedures and systems developed to
solve a health problem and improve quality of lives.’

Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:

Q1. Can you release your internal strategy regarding licensing and
patenting of COVID-19 related health technologies?

Q2. Does the institution have a formal policy on licensing and patenting
of COVID-19 related technologies? If yes, please provide a link or PDF to
the relevant policy document.

Q3. Has the university considered updating their strategy regarding the
licensing and patenting of health technologies since the start of the
pandemic?

Q4. Please provide an Excel spreadsheet with headings as displayed below
with all the COVID-19 related health technologies LICENSED by the
university AND specify which countries they were licensed in AND specify
whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

Q5. Please provide a list of patents granted to your organization for any
COVID-19 related health technologies listed by patent family, indicating
countries/regions in which the patent has been granted.

Q6. Does the institution have any plans on signing up to the Open-COVID
pledge ([5]https://opencovidpledge.org/) or any similar initiative that
seeks to minimise intellectual property rights barriers during the
COVID-19 pandemic? If yes, please specify.

Q7. Is the institution considering the licensing of COVID-19 related
health technologies to the Covid Technology Access Pool (C-TAP) or the
Medicines Patent Pool (MPP) during the pandemic? If yes, please specify.

END FOI request.

If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[FOI #702214 email]

Is [Keele University request email] the wrong address for Freedom of Information requests
to Keele University? If so, please contact us using this form:

[6]https://www.whatdotheyknow.com/change_re...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[7]https://www.whatdotheyknow.com/help/offi...

For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:

[8]https://www.whatdotheyknow.com/help/ico-...

Please note that in some cases publication of requests and responses will
be delayed.

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

References

Visible links
1. mailto:[email address]
2. http://www.keele.ac.uk/foi/
4. https://tinyurl.com/y5dwc2qv
5. https://opencovidpledge.org/
6. https://www.whatdotheyknow.com/change_re...
7. https://www.whatdotheyknow.com/help/offi...
8. https://www.whatdotheyknow.com/help/ico-...

foi, Keele University

1 Attachment

Dear Sarai, 
Ref: 2020/224/LN 
 

Further to your request for information, please find the University's
response below. 

Where you asked: 

Q1. Can you release your internal strategy regarding licensing and
patenting of COVID-19 related health technologies?  

​Keele's intellectual property strategy is framed by its charitable status
and academic mission as set out it is charter.  The University prioritises
the longer term dissemination and use of knowledge to enable wider
societal impact over shorter term commercial returns to the University. 
This includes licensing and patenting of COVID-19 related health
technologies.    

Q2. Does the institution have a formal policy on licensing and patenting
of COVID-19 related technologies? If yes, please provide a link or PDF to
the relevant policy document.   

[1]https://www.keele.ac.uk/policyzone/data/...

Q3. Has the university considered updating their strategy regarding the
licensing and patenting of health technologies since the start of the
pandemic?   

The University's current licensing and patenting strategy is appropriate
for its civic contribution to the pandemic and no update was considered
necessary. 

Q4. Please provide an Excel spreadsheet with headings as displayed below
with all the COVID-19 related health technologies LICENSED by the
university AND specify which countries they were licensed in AND specify
whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)  ​None 

Q5. Please provide a list of patents granted to your organization for any
COVID-19 related health technologies listed by patent family, indicating
countries/regions in which the patent has been granted.  

Granted patents are a matter of public record and can be searched by such
databases as [2]https://worldwide.espacenet.com/ 

Q6. Does the institution have any plans on signing up to the Open-COVID
pledge ([3]https://opencovidpledge.org/) or any similar initiative that
seeks to minimise intellectual property rights barriers during the
COVID-19 pandemic? If yes, please specify.  

Keele prioritises societal impact and will make available any COVID-19
technologies as appropriate.  Open access is not always the most
appropriate strategy for health-related technologies as the commercial
model has to be appropriate for investment. 

Q7. Is the institution considering the licensing of COVID-19 related
health technologies to the Covid Technology Access Pool (C-TAP) or the
Medicines Patent Pool (MPP) during the pandemic? If yes, please specify.  

Keele will consider licensing of COVID-19 related health technologies to
the Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool
(MPP) if it is considered the most appropriate mechanism.  

 

Should you have any queries, please don't hesitate to contact me. 

Best wishes,
Laura Norcop
Governance Officer

__________________________________________ 

Freedom of Information 

Legal, Governance & Compliance
Student and Academic Services
Tawney Building | Keele University | Staffordshire | ST5 5BG 

Email: [4][Keele University request email] | Website: [5]www.keele.ac.uk/foi/
Tel: Lauren A 34311 | Laura N: 34633 | Jo S: 33589 

[6]Please consider the environment before printing

This email and its attachments may be confidential; if it has come to you
in error you should not copy or show it to anyone; nor should you take any
action based on it, other than to notify the sender immediately. 

--------------------------------------------------------------------------

From: Sarai Keestra <[FOI #702214 email]>
Sent: 27 October 2020 12:22
To: foi <[Keele University request email]>
Subject: Freedom of Information request - UAEM - Licensing and patenting
practices of COVID-19 technologies
 
Dear Keele University,

For the purpose of clarity, please adhere to the following definitions
when answering these questions:

Low and middle income country: A country that is defined as ‘low’,
‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year
2018. Income status defined by GNI per capita.

Source: World bank, available online [[7]https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention.
A patent holder can stop other people from selling, manufacturing,
producing, or using the invention for a certain period of time.

Source: Upcouncil, available online
[https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property
rights

Source: TaylorWessing, available online
[https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to
exploit the relevant IP rights, the licensor is also excluded from
exploiting these IP rights.

Non-Exclusive Licence: A licence that grants any number of licensees to
exploit the IP.

Source: TaylorWessing, available online
[https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health
technology is the application of organized knowledge and skills in the
form of devices, medicines, vaccines, procedures and systems developed to
solve a health problem and improve quality of lives.’

Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:

Q1. Can you release your internal strategy regarding licensing and
patenting of COVID-19 related health technologies?

Q2. Does the institution have a formal policy on licensing and patenting
of COVID-19 related technologies? If yes, please provide a link or PDF to
the relevant policy document.

Q3. Has the university considered updating their strategy regarding the
licensing and patenting of health technologies since the start of the
pandemic?

Q4. Please provide an Excel spreadsheet with headings as displayed below
with all the COVID-19 related health technologies LICENSED by the
university AND specify which countries they were licensed in AND specify
whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

Q5. Please provide a list of patents granted to your organization for any
COVID-19 related health technologies listed by patent family, indicating
countries/regions in which the patent has been granted.

Q6. Does the institution have any plans on signing up to the Open-COVID
pledge ([8]https://opencovidpledge.org/) or any similar initiative that
seeks to minimise intellectual property rights barriers during the
COVID-19 pandemic? If yes, please specify.

Q7. Is the institution considering the licensing of COVID-19 related
health technologies to the Covid Technology Access Pool (C-TAP) or the
Medicines Patent Pool (MPP) during the pandemic? If yes, please specify.

END FOI request.

If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[FOI #702214 email]

Is [Keele University request email] the wrong address for Freedom of Information requests
to Keele University? If so, please contact us using this form:

[9]https://www.whatdotheyknow.com/change_re...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[10]https://www.whatdotheyknow.com/help/offi...

For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:

[11]https://www.whatdotheyknow.com/help/ico-...

Please note that in some cases publication of requests and responses will
be delayed.

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

References

Visible links
1. https://www.keele.ac.uk/policyzone/data/...
2. https://worldwide.espacenet.com/
3. https://opencovidpledge.org/
4. mailto:[email address]
5. http://www.keele.ac.uk/foi/
7. https://tinyurl.com/y5dwc2qv
8. https://opencovidpledge.org/
9. https://www.whatdotheyknow.com/change_re...
10. https://www.whatdotheyknow.com/help/offi...
11. https://www.whatdotheyknow.com/help/ico-...